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The possible role of protein kinase-C (PKC), calcium and cyclic AMP (CAMP) in mediating the metabolic and mitogenic 
effects of insulin-like growth factor-1 (IGF-I) on chondrocytes was investigated using a PKC activator (phorbol ester 
12,13-dibutyrate, PDBU), a PKC inhibitor (compound H7), a calcium channel blocker, (verapamil) and a CAMP ana- 
logue (dibutyryl CAMP). IGF-I and PDBU stimulated sulphate and thymidine incorporation by chondrocytes. Both of 
these effects were inhibited by compound H7. Verapamil inhibited IGF-I- and PDBU-stimulated sulphate incorporation, 
but contrastingly stimulated basal and enhanced IGF-I and PDBU stimulation of thymidine incorporation. Dibutyryl 
CAMP increased basal and IGF-I-stimulated sulphate incorporation but inhibited both basal and IGF-I stimulation of 
thymidine incorporation. These results suggest a harmonic overlap between the activities of PKC and CAMP-dependent 
PKA enzyme systems, and calcium balance in the mitogenic and metabolic process of the chondrocyte. 
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1. INTRODUCTION 
Insulin-like growth factor (IGF-I) is one of a 
family of growth hormone-dependent peptides 
which are mitogenic for a variety of tissues. They 
stimulate the uptake of sulphate into chondroitin 
sulphate of cartilage proteoglycans and thymidine 
into chondrocyte DNA [l]. 
Phorbol esters are mitogenic for a variety of 
tissues activating directly the enzyme protein 
kinase C (PKC) [2,3]. This is a phospholipid- and 
calcium-dependent enzyme normally activated by 
diacylglycerol produced from the breakdown of 
inositol phospholipids in cell membranes in 
response to external stimuli including receptor ac- 
tivation. Phorbol esters mimic the action of 
diacylglycerol thus activating PKC [4]. 
The nature of the intracellular factor(s) which 
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may act as secondary messengers for IGF action on 
chondrocytes is uncertain. This preliminary study 
addresses the possible involvement of PKC, 
calcium and cyclic AMP (CAMP) in IGF-I stimula- 
tion of chondrocyte metabolism by observing the 
effects of a PKC activator (phorbol ester 
12,13_dibutyrate, PDBU), a PKC inhibitor 
[1-(5-isoquinolinylsulphonyl)-2-methylpiperazine, 
H7), a calcium antagonist (verapamil) and a CAMP 
analogue (ZV6,02-dibutyryl adenosine 3 ‘,5’-cyclic 
monophosphoric acid) on basal and IGF-I- 
stimulated [3sS]sulphate and [3H]thymidine uptake 
by monolayer cultures of porcine articular chon- 
drocytes. 
2. MATERIALS AND METHODS 
Porcine weanling knee joints were obtained from the Animal 
Virus Research Institute at Pirbright (Surrey, England). Col- 
lagenase (clostridial type II, Worthington) was obtained from 
Lorne Diagnostics (Bury St. Edmunds, England). 
Hyaluronidase, phorbol ester, compound H7, verapamil and 
dibutyryl CAMP were obtained from Sigma (Poole, England). 
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Ham’s F12 medium, penicillin/streptomycin and fungizone 
were obtained from Flow Labs (Irvine, Scotland). Na:‘SOd and 
[3H]thymidine were obtained from Amersham (Bucks, 
England). 
IGF-I was prepared as reported in [5]. Due to paucity of pure 
IGF-I, partially purified IGF-I from an early stage of purifica- 
tion with an immunoactivity of 37 U/mg protein was used. 
2.1. Isolation of articular chondrocytes and cell culture 
The knee joints were opened under aseptic conditions shortly 
after slaughter; cartilage from the articular facets was removed 
and collected into a sterile solution of ice-cold phospho-saline 
buffer (PBS), supplemented with penicillin/streptomycin 
(100 U/lOO,ug per ml) and fungizone (2pg/ml), and trans- 
ported back to the laboratory. 
The cartilage slices were chopped into fine pieces, washed ex- 
tensively in PBS and digested overnight in an air incubator, on 
a magnetic stirrer, in Ham’s F12 medium containing a I : 1 mix- 
ture of collagenase and hyaluronidase (1 mg/ml), with the addi- 
tion of 5% fetal calf serum. The digestion volume per batch of 
cartilage was 50 ml. The final digest was filtered through sterile 
nylon gauze in order to remove any undigested material and the 
cells were centrifuged at 1500 rpm for 5 min. The cellular pellet 
was washed and centrifuged (x 3) in serum-free medium and 
resuspended in Ham’s F12 medium supplemented with 10% 
fetal calf serum. Cells were seeded out at high density into 
250-ml tissue culture flasks in order to maintain a chondrocytic 
phenotype, and grown to confluency. 
For these experiments, sufficient cell numbers were usually 
obtained after three passa es. cells were then seeded out at high 
,P : 
density into 50.mm culture dashes, grown to confluency before 
being used for experiments (see fig.1). The mean cell number 
per culture dish at confluency was (4.1 k 0.38) x lo5 (SD), the 
coefficient of variation in cell number per dish being 9.2% 
(n = 10) by Coulter counter. Cell viability was determined by 
trypan blue dye exclusion and was consistently greater than 
90%. Only cells isolated from the articular cartilage of one 
animal were used for each set of experiments, minimising intra- 
assay variation. 
2.2. Sulphate and thymidine incorporation 
Cell cultures were growth-arrested for 24 h in serum-free 
medium (Ham’s). Duplicate cultures were then incubated for a 
further 24 h (sulphate incorporation) and 48 h (thymidine in- 
corporation) in Ham’s F12 medium in the presence of IGF-I 
and/or PDBU alone at various concentrations and with the ad- 
dition of H7, verapamil and/or dibutyryl CAMP at various con- 
centrations. [“S]Sulphate and [‘Hlthymidine were used at 
2 pCi/ml. 
At the end of the incubation the culture medium was 
aspirated and the cell monolayers were washed extensively with 
cold PBS until background levels of radioactivity were observed 
in the washes. The cell monolayers were then dissolved in 2 ml 
of 2 M KOH solution, 250 pl aliquots diluted 1: 4 with distilled 
water and after addition of 4 ml toluene-based scintillant 
counted for radioactivity in a liquid scintillation p-counter. 
Four aliquots from each of duplicate cultures represented 
each concentration of test substance. All results are expressed 
as a percentage of basal radionuclide incorporation by chon- 
drocytes. Values of basal cpm (100%) & SE of each group of 8 
observations are stated for each figure. The standard error of 
the mean of each group of observations was always ~8%. 
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Fig. 1. Articular chondrocyte monolayer cultures: comparison 
of high- and low-density seeding. Note the appearance of cells 
with a fibroblastic-like phenotype at low-density seeding, as in- 
dicated by the arrows. 
.3 RESULTS 
Chondrocyte uptake of both [35S]sulphate and 
[3H]thymidine was stimulated by IGF-I and PDBU 
(figs 2-5). Basal, IGF-I- and PDBU-stimulated 
[35S]sulphate and [3H]thymidine uptake by chon- 
drocytes was inhibited by compound H7 (figs 2,3). 
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Fig.2. Effect of a protein kinase C inhibitor (H7) on basal, IGF-I- and phorbol ester (12,13-dibutyrate)-stimulated [35S]sulphate uptake 
by chondrocytes. 
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Fig.3. Effect of a protein kinase C inhibitor (H7) on basal, IGF-I- and phorbol ester (12,13-dibutyrate)-stimulated [‘Hlthymidine up- 
take by chondrocytes. 
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Fig.4. Effect of a calcium channel antagonist (verapamil) on basal, IGF-I- and phorbol ester (12,13-dibutyrate)-stimulated [“S]sul- 
phate uptake by chondrocytes. 
Verapamil inhibited both IGF-I- and PDBU- 
stimulated [35S]sulphate uptake, but had little ef- 
fect upon basal sulphate incorporation by chon- 
drocytes, suggesting that extracellular calcium 
influx may be involved in the metabolic effects of 
IGF-I and PDBU on chondrocytes (see fig.4). In 
contrast, verapamil caused an increase in basal and 
a marked enhancement of both IGF-I- and PDBU- 
stimulated t3H]thymidine uptake by chondrocytes 
(see fig.5), suggesting that the mitogenic effects of 
IGF-I and PDBU may involve PKC activity in- 
dependent of extracellular calcium influx (see 
fig.5). Dibutyryl CAMP increased basal and IGF-I- 
stimulated [35S]sulphate uptake by chondrocytes, 
but constrastingly inhibited basal and IGF-I 
stimulation of [3H]thymidine uptake by chon- 
drocytes (see fig.6). 
4. DISCUSSION 
Our data demonstrate that IGF-I and PDBU 
stimulated [35S]sulphate and [3H]thymidine uptake 
36 
by porcine articular chondrocytes in vitro. The up- 
take of these labels is inhibited by H7, a potent in- 
hibitor of PKC [a]. Since phorbol esters stimulate 
PKC directly and the action of IGF-I is inhibited 
by H7, it was concluded that PKC mediates both 
the metabolic and mitogenic actions of IGF-I. 
However, since H7 inhibits the CAMP-dependent 
PKA enzyme system, this would not exclude a 
possible role for PKA in mediating the mitogenic 
and metabolic effects of IGF-I. 
However, PKA activity is associated with an in- 
crease in levels of intracellular CAMP and in this 
system the addition of the CAMP analogue 
dibutyryl CAMP inhibited [3H]thymidine incor- 
poration. 
The inhibition of PKA activity by H7 would be 
associated with low levels of CAMP and since 
dibutyryl CAMP itself inhibits thymidine incor- 
poration by chondrocytes the inhibition of the 
mitogenic effects of both IGF-I and PDBU by H7 
is unlikely to involve PKA activity, but rather in- 
volves the inhibition of PKC activity or some other 
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Fig.5. Effect of a calcium channel antagonist (verapamil) on basal, IGF-I- and phorbol ester (12,13-dibutyrate)-stimulated [‘HI- 
thymidine uptake by chondrocytes. 
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Fig.6. Effect of dibutyryl CAMP on basal and IGF-I-stimulated [“sS]sulphate and [3H]thymidine uptake by chondrocytes. 
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as yet unknown enzyme system. Inhibition of H7 
or IGF-I- and PDBU-stimulated [35S]sulphate in- 
corporation by chondrocytes is probably associat- 
ed with inhibition of PKA activity, since dibutyryl 
CAMP increases basal and IGF-I stimulation of 
sulphate uptake by chondrocytes, suggesting that 
the metabolic effects of IGF-I may be mediated by 
the CAMP-dependent PKA system. 
The effect of verapamil, a Ca2+ antagonist [7], 
on basal, IGF-I- and phorbol ester-stimulated 
[35S]sulphate uptake by chondrocytes was also in- 
hibitory; this is consistent with previous data on 
the role of intracellular calcium in mediating secre- 
tion and inducing stimulation in various 
cellular/tissue systems. 
The most intriguing observation however, was 
that verapamil stimulated basal [3H]thymidine up- 
take by chondrocytes and enhanced the 
stimulatory action of IGF-I and PDBU. Whereas 
verapamil has been shown to stimulate and 
calcium to inhibit secretory processes in some cell 
systems [8], verapamil has never been shown to 
have a divergent effect on the secretory and mitotic 
processes within the same cell. By implication, 
calcium plays different roles in regulating the 
secretory and mitotic processes in the chondrocyte. 
Thus, while calcium entry into the cell appears to 
be cardinal in mediating the metabolic effects of 
IGF-I and PDBU, calcium is inhibitory to mito- 
genesis. The mediation of mitogenesis due to IGF-I 
and PDBU may therefore be mediated by other 
postulated mechanisms, such as activation of the 
Na+/H+ pump; in our chondrocyte cell system, 
amiloride, an inhibitor of the Na+/H+ exchange 
pump inhibits IGF-I stimulation of [3H]thymidine 
uptake by chondrocytes (unpublished). 
The fact that a calcium channel blocker has dif- 
ferential effects on IGF-I-induced secretory and 
mitotic processes in the chondrocyte raises the 
possibility that IGF-I may mediate these effects 
through two distinct receptor and receptor-linked 
enzyme systems. However, the fact that verapamil 
has qualitatively similar effects on basal and phor- 
bol ester-stimulated cells, implies that this dif- 
ferential effect of calcium blockade is mediated 
through intracellular enzyme-linked processes at a 
post-receptor level rather than through distinct 
receptors. 
In conclusion, these preliminary results suggest 
that the PKC enzyme system may play a role in the 
mediation of the mitogenic effects of IGF-I and 
PDBU in the chondrocyte independently of extra- 
cellular calcium influx. The CAMP-dependent 
PKA enzyme system may play a counter- 
regulatory role in this process. Also, the metabolic 
effects of IGF-I may be mediated by PKA activity 
dependent upon extracellular calcium influx. 
These results suggest a harmonic overlap be- 
tween the activities of PKC and PKA enzyme 
systems in the mitogenic and metabolic processes 
of the chondrocyte. In addition, intracellular levels 
of CAMP and/or calcium balance may be impor- 
tant factors in determining the expression of either 
the metabolic or mitogenic message of IGF-I in the 
chondrocyte. 
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